A report from the Peterson Health Technology Institute found that virtual gastrointestinal solutions can improve symptoms for patients with Irritable Bowel Syndrome and Inflammatory Bowel Disease while lowering healthcare spending.
Chicago-based gastroenterologist Larry Kosinski of the Illinois Gastroenterology Group is excited by the prospects for SonarMD, the population health company he founded and for which he serves as Chief Medical Officer.
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
Expanding the oral targeted therapy offerings for GI diseases like IBD, Protagonist Therapeutics plans to go up against the blockbusters like Humira and Remicade